For today’s Journal Review installment, we’re flipping our calendars back to 2017. Our highlighted study shows that even back then, there was a basis for further exploration of CBD’s impact on the brain. This is another journal article that took place prior to the passing of the 2018 Farm Bill. For those unaware, this was the legislation that made hemp legal on a federal level.
That means across the board, hemp that has under a certain amount of THC (0.3% to be exact) is completely legal. There are of course further regulations and stipulations to be aware of and abide by. But one of the main benefits of this is that it opens the door to newer, more in depth study, free from legal restriction.
Neurological Effects Of CBD
The study sought “to describe the state of art about the pre-clinical research… potential use and, when existing, the clinical evidence [of] CBD in the neurological field.” Researchers took this chance to track its effects in the presence of various neurological diseases. The afflictions in question are listed in further detail below.
- Parkinson’s disease (PD)
- Alzheimer’s disease (AD)
- Multiple Sclerosis (MS)
- Huntington’s disease (HD)
- Amyotrophic Lateral Sclerosis (ALS)
- Cerebral Ischemia
Journal Review With Arbor Vita8
The findings showed a wealth of noteworthy positive impacts from CBD on a number of the diseases that impact the brain. But like most of the studies before it, legal limitations necessitated further, more expansive study. Thankfully, we’d continue moving towards a more forward thinking future, with the landmark Farm Bill less than 12 months from being realized.
At Arbor Vita8, we’re dedicated to keeping you up to date on all things hemp related. Check out our extensive collection of blogs on our Resource tab, here. If you have any more questions, don’t hesitate to reach out to us. You can schedule a consultation with us here!
